176 related articles for article (PubMed ID: 35414767)
1. Claudin-10 overexpression suppresses human clear cell renal cell carcinoma growth and metastasis by regulating ATP5O and causing mitochondrial dysfunction.
Yang W; Zhang K; Zhang Z; Zhou J; Li L; Xu Y; Qiu J; Cai L; Gong Y; Gong K
Int J Biol Sci; 2022; 18(6):2329-2344. PubMed ID: 35414767
[TBL] [Abstract][Full Text] [Related]
2. CLDN10 associated with immune infiltration is a novel prognostic biomarker for clear cell renal cell carcinoma.
Yang W; Li L; Zhang K; Ma K; Gong Y; Zhou J; Gong K
Epigenomics; 2021 Jan; 13(1):31-45. PubMed ID: 33203244
[No Abstract] [Full Text] [Related]
3. Upregulation of homeobox D10 expression suppresses invasion and migration of clear cell renal cell carcinoma through targeting of E-cadherin.
Ren Z; Niu Y; Fan B; Zhang A
Mol Biol Rep; 2022 Mar; 49(3):1837-1846. PubMed ID: 34825321
[TBL] [Abstract][Full Text] [Related]
4. MIOX inhibits autophagy to regulate the ROS -driven inhibition of STAT3/c-Myc-mediated epithelial-mesenchymal transition in clear cell renal cell carcinoma.
Meng L; Gao J; Mo W; Wang B; Shen H; Cao W; Ding M; Diao W; Chen W; Zhang Q; Shu J; Dai H; Guo H
Redox Biol; 2023 Dec; 68():102956. PubMed ID: 37977044
[TBL] [Abstract][Full Text] [Related]
5. Circ-AKT3 inhibits clear cell renal cell carcinoma metastasis via altering miR-296-3p/E-cadherin signals.
Xue D; Wang H; Chen Y; Shen D; Lu J; Wang M; Zebibula A; Xu L; Wu H; Li G; Xia L
Mol Cancer; 2019 Nov; 18(1):151. PubMed ID: 31672157
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
7. Capn4 contributes to tumor invasion and metastasis in clear cell renal cell carcinoma cells via modulating talin-focal adhesion kinase signaling pathway.
Zhuang Q; Luo W; Zhang M; Fan M; Lu H; Xu R; He X
Acta Biochim Biophys Sin (Shanghai); 2018 May; 50(5):465-472. PubMed ID: 29648579
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.
Shi L; Xiao L; Heng B; Mo S; Chen W; Su Z
Int Urol Nephrol; 2017 Jul; 49(7):1165-1176. PubMed ID: 28349447
[TBL] [Abstract][Full Text] [Related]
9. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
[TBL] [Abstract][Full Text] [Related]
10. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
[TBL] [Abstract][Full Text] [Related]
11. Aberrant Expression of E-cadherin, N-cadherin, and P-cadherin in Clear Cell Renal Cell Carcinoma: Association With Adverse Clinicopathologic Factors and Poor Prognosis.
Jang NR; Choi JH; Gu MJ
Appl Immunohistochem Mol Morphol; 2021 Mar; 29(3):223-230. PubMed ID: 32341236
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin-specific peptidase 53 inhibits the occurrence and development of clear cell renal cell carcinoma through NF-κB pathway inactivation.
Gui D; Dong Z; Peng W; Jiang W; Huang G; Liu G; Ye Z; Wang Y; Xu Z; Fu J; Luo S; Zhao Y
Cancer Med; 2021 Jun; 10(11):3674-3688. PubMed ID: 33973730
[TBL] [Abstract][Full Text] [Related]
13. Circ-APBB1IP as a Prognostic Biomarker Promotes Clear Cell Renal Cell Carcinoma Progression Through The ERK1/2 Signaling Pathway.
Mo J; Zhao Y; Ao Z; Chen L; Lin S; Zeng W; Wu H; Liu J
Int J Med Sci; 2020; 17(9):1177-1186. PubMed ID: 32547313
[TBL] [Abstract][Full Text] [Related]
14. ZNF582 overexpression restrains the progression of clear cell renal cell carcinoma by enhancing the binding of TJP2 and ERK2 and inhibiting ERK2 phosphorylation.
Yang W; Zhang Z; Li L; Zhang K; Xu Y; Xia M; Zhou J; Gong Y; Chen J; Gong K
Cell Death Dis; 2023 Mar; 14(3):212. PubMed ID: 36966163
[TBL] [Abstract][Full Text] [Related]
15. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of lncRNA APCDD1L-AS1 due to DNA hypermethylation and loss of VHL protein expression promotes the progression of clear cell renal cell carcinoma.
Yang W; Zhou J; Zhang Z; Zhang K; Xu Y; Li L; Cai L; Gong Y; Gong K
Int J Biol Sci; 2022; 18(6):2583-2596. PubMed ID: 35414787
[No Abstract] [Full Text] [Related]
17. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.
Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C
Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma.
Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X
J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019
[TBL] [Abstract][Full Text] [Related]
19. HSP60 silencing promotes Warburg-like phenotypes and switches the mitochondrial function from ATP production to biosynthesis in ccRCC cells.
Teng R; Liu Z; Tang H; Zhang W; Chen Y; Xu R; Chen L; Song J; Liu X; Deng H
Redox Biol; 2019 Jun; 24():101218. PubMed ID: 31112866
[TBL] [Abstract][Full Text] [Related]
20. CBX4 transcriptionally suppresses KLF6 via interaction with HDAC1 to exert oncogenic activities in clear cell renal cell carcinoma.
Jiang N; Niu G; Pan YH; Pan W; Zhang MF; Zhang CZ; Shen H
EBioMedicine; 2020 Mar; 53():102692. PubMed ID: 32113161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
